POET
POET Technologies Inc
NASDAQ: POET · TECHNOLOGY · SEMICONDUCTORS
$12.15
+1.67% today
Updated 2026-06-18
Market cap
$1.92B
P/E ratio
—
P/S ratio
1,358.51x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$4 – $21
Volume
44.9M
POET Technologies Inc (POET) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Research-backed POET price target 2030 projection accounting for share dilution, balance sheet debt, and time value of money.
Current price
$12.15
Today
Analyst consensus
$8.00
-34.16% · 12M
2030 Base
$0.06
-99.51% future
NPV today
$0.04
@ 9% WACC
1 analysts:
0 Buy0 Hold1 Sell
Management guidance
CEO Suresh Venkatesan has NOT provided specific forward revenue targets in public filings as of June 2026. However, management announced a $500M Lumilens supply deal (initial $50M order with potential $500M+ total value), secured $400M in strategic funding to expand manufacturing capacity 10x by 2027, and hired COO Dr. Sandeep Kumar to drive commercialization. These commitments imply management expects significant revenue acceleration post-2026, but no explicit CAGR or 2030 target has been disclosed.
Sources: Management guidance, analyst consensus, sector analysismedium confidence
POET · POET Technologies Inc · Revenue & price projection · 2023–2030E
Actual / 2030 target Projected revenue Base case price Bull to bear range
Bear case (2030)
$0.06
NPV today: $0.04
Base case (2030)
$0.06
NPV today: $0.04
Bull case (2030)
$0.06
NPV today: $0.04
WallStSmart.com
POET financial forecast · Research-backed projections
| Metric | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) ★ |
|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.2B | $0.3B | $0.4B |
| Revenue growth | 2494.6% | 647.0% | 962.0% | 118.0% | 68.0% | 39.0% |
| Net margin | — | -1341.6% | -71.4% | -14.1% | 6.7% | 11.4% |
| EPS | $-0.81 | $-0.62 | $-0.35 | $-0.15 | $0.12 | $0.28 |
| Diluted shares | — | 173M | 173M | 174M | 174M | 175M |
| Net debt | — | $-11.29M | $-11.29M | $-11.29M | $-11.29M | $-11.29M |
| P/S multiple | — | 623.5x | 623.5x | 623.5x | 623.5x | 623.5x |
| Implied price (base) | — | $0.07 | $0.07 | $0.06 | $0.06 | $0.06 |
★ 2030E is the model's terminal target year. Implied price = (Revenue × P/S − Net debt) ÷ Diluted shares.
Scenario detail · Three drivers, three outcomes
| 2030E driver | Bear | Base | Bull |
|---|---|---|---|
| Revenue | $0.4B | $0.4B | $0.4B |
| P/S multiple | — | — | — |
| Diluted shares | 175M | 175M | 175M |
| Net debt | $-11.29M | $-11.29M | $-11.29M |
| Implied P/E † | 0x | 0x | 0x |
| 2030 Price | $0.06 | $0.06 | $0.06 |
| NPV @ 9% | $0.04 | $0.04 | $0.04 |
† Implied P/E: Multiples remain elevated across all three scenarios because POET is valued primarily on revenue scale during its growth phase, not near-term earnings power. Lower P/E in the bear case reflects multiple compression, but the absolute level stays high since 2030E still represents a hypergrowth-to-mature transition year.
EV to per-share bridge · How we get to $0.06 base case
POET catalysts and risks
Growth catalysts
+ Lumilens $50M initial order execution + scaling to $500M+ over 2026-2028
+ Manufacturing capacity expansion 10x completion by 2027 enabling revenue ramp
+ AI optical interconnect market adoption by hyperscalers (Meta, Microsoft, Google capex $60B-$80B+ annually through 2028)
+ Potential new customer wins beyond Lumilens (Marvell relationship damaged; requires new strategic partnerships)
+ Resolution of pending class action lawsuits (13+ lawsuits filed June 2026 re: NDA violations and tax status misstatements)
Key risks
- Marvell Semiconductor canceled all purchase orders in April 2026 due to alleged NDA violations by company executive—demonstrates execution risk and partner concentration risk
- 13+ securities class action lawsuits filed alleging false statements regarding tax status (PFIC classification), creating legal/reputational overhang and potential shareholder dilution
- Material weakness in internal controls; accumulated deficit of $291M; negative gross margin (-31% in Q1 2026) indicates manufacturing cost structure not yet optimized for commercial scale
- Extreme share dilution: $150M raise (Jan 2026) + $400M raise (May 2026) = $550M in equity issuance in 6 months; pre-money valuation of $1.4B-$1.9B implies significant dilution to existing shareholders
- Pre-revenue/minimal revenue company ($1.07M annual revenue in 2025, $503K in Q1 2026) betting entire thesis on single major customer (Lumilens) and unproven manufacturing ramp
- Competitive risk: Broadcom, Intel, NVIDIA, and other optical interconnect players have far greater scale and capital resources
- Lumilens partnership is non-binding supply deal, not guaranteed demand; customer credit risk if Lumilens faces funding/operational challenges
Methodology · POET Technologies Inc 2030 stock forecast model
POET Technologies Inc 2030 price target is calculated using WallStSmart's research model. Revenue projections are derived from analyst consensus across 1 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts. The model is built on five core components:
| 1. Share dilution | Projected from per-ticker schedule of SBC + equity raise activity, compounding year by year (1% cumulative for POET by 2030) |
| 2. Net debt | EV minus net debt yields equity value; debt projected from capex cycle trajectory ($-11.29M by 2030) |
| 3. Time value | NPV calculated using 9% WACC (CAPM: beta 0.733) |
| 4. Multiple framework | P/S compresses with scale: bear — / base — / bull — |
| 5. Scenario design | Bull/Base/Bear vary revenue, margin, shares, debt, and multiple independently |
WallStSmart research model · Not financial advice · Past performance is not indicative of future results · Last researched: June 12, 2026.
POET price target FAQ
What is the POET price target for 2030?
WallStSmart's POET Technologies Inc 2030 base case is $0.06 per share, with a bull case of $0.06 and bear case of $0.06. The NPV of the base case discounted to today at 9% WACC is $0.04.
How is the POET Technologies Inc 2030 stock forecast calculated?
The POET 2030 projection multiplies projected revenue by a growth-adjusted P/S multiple to derive enterprise value, subtracts projected net debt to get equity value, then divides by diluted shares outstanding accounting for dilution from stock-based compensation and equity raises.
Why does the POET price target account for dilution?
POET Technologies Inc is projected to grow diluted share count from 173M to 175M by 2030 (a 1% increase) through stock-based compensation and capital raises. Ignoring this would inflate the price target by approximately 1%.
What is the analyst consensus on POET stock?
1 analysts cover POET with an average 12-month price target of $8.00. The 2030 projection extends this framework with longer-horizon assumptions including dilution and time value of money.